SHANNAN RENE BRYANT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology DENVER, CO NPI 1225635477
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology CO Relypsa, Inc. All categories
General Payments — all program years on this page
$577.32
- Category: General Payments
- Program years: PY2021–2024
- Record count: 20
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $304.98 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.98 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Relypsa, Inc. | $146.51 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $46.52 | 2 |
| Amgen Inc. | $29.89 | 1 |
| Otsuka America Pharmaceutical, Inc. | $29.19 | 1 |
| Aurinia Pharma U.S., Inc. | $27.99 | 1 |
| GlaxoSmithKline, LLC. | $24.88 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1116548881 | GlaxoSmithKline, LLC. | $24.88 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117212163 | Amgen Inc. | $29.89 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119035417 | Otsuka America Pharmaceutical, Inc. | $29.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124045723 | Vifor Pharma, Inc. | $31.94 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124050493 | Vifor Pharma, Inc. | $114.57 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141510573 | CALLIDITAS THERAPEUTICS US INC. | $22.25 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141522817 | CALLIDITAS THERAPEUTICS US INC. | $24.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150695692 | Aurinia Pharma U.S., Inc. | $27.99 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.